Thus, SLC26A3 inhibited the nucleus translocation of NF-κB/p65 promoting the transcription of SLC26A3, thereby establishing a positive regulatory feedback loop to suppresses the malignant biology of CRC cells. The gene discussed is NFKB1; the disease is colorectal carcinoma.